---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-21-009299"
form_type: "8-K"
ticker: "CAPR"
cik: "0001133869"
company_name: "CAPRICOR THERAPEUTICS, INC."
filed_at: "2021-07-27T23:59:59+00:00"
generated_at: "2026-06-30T02:04:29.176246+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Capricor Therapeutics appoints Karimah Es Sabar to Board of Directors

## Summary
- Karimah Es Sabar appointed to Capricor's Board of Directors effective July 23, 2021.
- She brings over 35 years of biopharma leadership, drug development, and venture investing experience.
- Es Sabar currently serves as CEO and Partner at Quark Venture LP.
- She will receive standard non-employee director compensation under Company policies.
- Previously held senior roles at CDRD and Sanofi Pasteur; holds degrees in neurochemistry and biochemistry.

## SEC filing metadata
- accession: 0001558370-21-009299
- form_type: 8-K
- ticker: CAPR
- cik: 0001133869
- company_name: CAPRICOR THERAPEUTICS, INC.
- filed_at: 2021-07-27T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133869/000155837021009299/0001558370-21-009299-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133869/000155837021009299/tmb-20210723x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-21-009299
- JSON: https://secwatch.observer/filing/0001558370-21-009299.json
- Plain text: https://secwatch.observer/filing/0001558370-21-009299.txt

## Key facts
- Executive change
  Karimah Es Sabar was elected as Director at CAPRICOR THERAPEUTICS, INC..
  - Action: elected
  - Role: Director
  source text: On July 23, 2021, the Board of Directors of Capricor Therapeutics, Inc., a Delaware corporation (the “Company”), elected Karimah Es Sabar as a member of the Company’s Board of Directors (the “Board”) effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1133869/000155837021009299/0001558370-21-009299-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.